Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Radioiodine-Unresponsive Thyroid Carcinomas
NCT00026533Phase 2Completed
- Start
- Jun 2001
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in Papillary Thyroid Carcinoma (PTC), Follicular thyroid carcinoma (FTC), Medullary Thyroid Carcinoma (MTC). Started Jun 2001; status: completed.
02
Drugs
thalidomide
03
Conditions
Papillary Thyroid Carcinoma (PTC)Follicular thyroid carcinoma (FTC)Medullary Thyroid Carcinoma (MTC)
Beyond the preview
Go deeper on NCT00026533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026533.